Quickly Spot Consensus Among the World’s Best Equity Analysts
| Name | Upside % |
Analysts bullish % |
|
|---|---|---|---|
|
126%
upside
4 price targets
|
0
%
|
|
|
|
124%
upside
3 price targets
|
0
%
|
|
|
|
120%
upside
3 price targets
|
0
%
|
|
|
29
Nuvation Bio
NUVB
$1.67B
|
116%
upside
3 price targets
|
0
%
|
|
|
115%
upside
4 price targets
|
0
%
|
|
|
|
113%
upside
3 price targets
|
0
%
|
|
|
|
109%
upside
4 price targets
|
0
%
|
|
|
|
108%
upside
4 price targets
|
0
%
|
|
|
|
108%
upside
6 price targets
|
0
%
|
|
|
|
102%
upside
4 price targets
|
0
%
|
|
|
36
Capricor Therapeutics
CAPR
$1.76B
|
99%
upside
3 price targets
|
0
%
|
|
|
97%
upside
5 price targets
|
0
%
|
|
|
|
97%
upside
3 price targets
|
0
%
|
|
|
|
96%
upside
8 price targets
|
0
%
|
|
|
|
96%
upside
3 price targets
|
0
%
|
|
|
|
95%
upside
3 price targets
|
0
%
|
|
|
|
95%
upside
3 price targets
|
0
%
|
|
|
|
93%
upside
9 price targets
|
0
%
|
|
|
|
92%
upside
7 price targets
|
0
%
|
|
|
|
92%
upside
5 price targets
|
0
%
|
|
|
|
92%
upside
4 price targets
|
0
%
|
|
|
|
88%
upside
4 price targets
|
0
%
|
|
|
|
88%
upside
4 price targets
|
0
%
|
|
|
|
87%
upside
5 price targets
|
0
%
|
|
|
|
84%
upside
3 price targets
|
0
%
|
|